Soft-tissue Sarcomas

Area of Science:

• Oncology
• Musculoskeletal Oncology
• Surgical Oncology

Background:

• Soft-tissue sarcomas (STS) are rare, heterogeneous malignancies originating from connective tissues.
• Effective management requires specialized multidisciplinary teams and referral centers.
• Historically, amputation was the primary treatment for local control.

Purpose of the Study:

• To discuss the epidemiology, diagnosis, and management of primary soft-tissue sarcomas.
• To highlight the evolution of treatment strategies towards limb preservation.
• To identify challenges in local disease control, particularly unplanned surgical excisions.

Main Methods:

• Review of current literature on soft-tissue sarcoma epidemiology.
• Analysis of diagnostic approaches for STS.
• Evaluation of evolving surgical and multimodality treatment strategies.
• Discussion of outcomes related to limb-sparing surgery versus historical amputation rates.

Main Results:

• Multimodality treatment has shifted focus to limb preservation, significantly improving patient quality of life.
• Limb-sparing surgery represents a major advancement in sarcoma care.
• Unplanned surgical excision of STS presents a persistent challenge for achieving local disease control.

Conclusions:

• Optimal management of soft-tissue sarcomas necessitates specialized, multidisciplinary care.
• Advances in limb-sparing surgery have improved outcomes, but require careful planning.
• Addressing challenges associated with unplanned excisions is crucial for enhancing local disease control in STS patients.